IN
INNOCAN PHARMA Corp
INNPF · OTC
$1.60 -8.05% (-$0.14)
1M +18.24%
Market Cap $7.20M
P/E Ratio -
Div. Yield -
ROE 13.58%
Piotroski F-Score Weak
3/9Valuation
99 /100
Cheap P/S 0.24x
P/B 1.71x
EV/EBITDA 1.14x
Growth
-
N/A Book val. growth N/A
FCF growth N/A
EPS growth N/A
Profitability
22 /100
Weak FCF margin 0.54%
Op. margin 1.22%
Gross margin 88.90%
Quality
17 /100
Poor Asset turnover 2.69x
ROA 5.95%
ROIC 1.93%
Debt
99 /100
Low Net debt/EBITDA -5.00x
Int. coverage 126.33x
Debt/Equity 0.33x
Stability
50 /100
Moderate Beta -0.22x
EPS volatility N/A
Profitable years N/A
Bulios Scoring popisuje kvalitu a minulost firmy, ne budoucí výnos. Vysoké skóre není nákupní signál. Zjistit více
Zeptejte se StockBota na INNPF
Online
Sector
Healthcare
Industry
Medical - Pharmaceuticals
CEO
Iris Bincovich
Employees
11
Headquarters
Calgary